Search
Search
About
Log in
Join
Experiences with
Prialt
Posts
Communities
5,284 public posts
Filter results
The Day I Raced My Palliative Care Nurse
I’m coming off the mountain top! What an incredible experience and I’m sure Nurse Sarah (not her real name) feels the same! I was smiling and laughing all the way home from my hospital! So much fun! I can only say in my life that my wife’s birth to our daughters surpasses this. The only thing that
I’m coming off the mountain top! What an incredible experience and I’m sure Nurse Sarah (not her real name) feels the same! I was smiling and laughing all the way home from my hospital! So much fun! I can only say in my life that my wife’s birth to our daughters surpasses this. The only thing that
TuffNuttoCrack
in
Advanced Prostate Cancer
2 days ago
Vomorolone vs Prednisone
Vomorolone is not currently approved for use in treatment of PMR. I'm just posting this so everyone is aware of its existence. There are also currently no clinical trials for its use with PMR, but here is what preplexityai.com says: https://www.perplexity.ai/search/are-there-any-clinical-trials-hK1KGkNsRcG1XeWQNI5g4g
Vomorolone is not currently approved for use in treatment of PMR. I'm just posting this so everyone is aware of its existence. There are also currently no clinical trials for its use with PMR, but here is what preplexityai.com says: https://www.perplexity.ai/search/are-there-any-clinical-trials-hK1KGkNsRcG1XeWQNI5g4g
Ackgolfer63
in
PMRGCAuk
4 days ago
Help: Use of ODM 208 during Phase 3 clinical trials to replace Docetaxel for treatment after Abiraterone - Case Peru
Hello, my father suffers from prostate cancer with bone metastasis. He was taking Abiraterone, and because the cancer has advanced and his PSA has increased in recent months, the use of Abiraterone was cancelled. Now they have suggested chemotherapy with Docetaxel + Celendronic Acid. The hospital contacted
Hello, my father suffers from prostate cancer with bone metastasis. He was taking Abiraterone, and because the cancer has advanced and his PSA has increased in recent months, the use of Abiraterone was cancelled. Now they have suggested chemotherapy with Docetaxel + Celendronic Acid. The hospital contacted
DiegoFerruaPE
in
Advanced Prostate Cancer
6 days ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Seeking Advice on Clinical Trials or Treatments for Advanced Prostate Cancer with Bone Marrow Involvement
Dear Forum Members, I am reaching out for guidance and support regarding my father’s ongoing battle with advanced prostate cancer. About a year ago, he was diagnosed with stage 4 prostate cancer with extensive bone metastases but no organ involvement. Recently, we discovered that he has a BRCA2 mutation
Dear Forum Members, I am reaching out for guidance and support regarding my father’s ongoing battle with advanced prostate cancer. About a year ago, he was diagnosed with stage 4 prostate cancer with extensive bone metastases but no organ involvement. Recently, we discovered that he has a BRCA2 mutation
Fightingformyfather
in
Advanced Prostate Cancer
8 days ago
FDA grants fast track designation to CAR T-cell therapy for SLE
FDA grants fast track designation to CAR T-cell therapy for SLE Caribou's CB-010 candidate designed for treatment-resistant lupus by Andrea Lobo, PhD The U.S. Food and Drug Administration (FDA) has granted fast track designation to Caribou Biosciences‘ CAR T-cell therapy CB-010 for systemic lupus
FDA grants fast track designation to CAR T-cell therapy for SLE Caribou's CB-010 candidate designed for treatment-resistant lupus by Andrea Lobo, PhD The U.S. Food and Drug Administration (FDA) has granted fast track designation to Caribou Biosciences‘ CAR T-cell therapy CB-010 for systemic lupus
lupus-support1
Administrator
in
LUpus Patients Understanding and Support
9 days ago
Recent research re. relevance of VAF
MPN Hub summary
Impact of mutated JAK2 allele burden on the outcomes in PV and ET
of a recent article by Guglielmelli et al. durable molecular response (DMR) complete clinical and hematological response (CCHR) [i]"Increased DMR was correlated with longer duration of CCHR, reduced progression
MPN Hub summary
Impact of mutated JAK2 allele burden on the outcomes in PV and ET
of a recent article by Guglielmelli et al. durable molecular response (DMR) complete clinical and hematological response (CCHR) [i]"Increased DMR was correlated with longer duration of CCHR, reduced progression
hunter5582
in
MPN Voice
9 days ago
Recent research re. relevance of VAF
MPN Hub summary
Impact of mutated JAK2 allele burden on the outcomes in PV and ET
of a recent article by Guglielmelli et al. durable molecular response (DMR) complete clinical and hematological response (CCHR) [i]"Increased DMR was correlated with longer duration of CCHR, reduced progression
MPN Hub summary
Impact of mutated JAK2 allele burden on the outcomes in PV and ET
of a recent article by Guglielmelli et al. durable molecular response (DMR) complete clinical and hematological response (CCHR) [i]"Increased DMR was correlated with longer duration of CCHR, reduced progression
hunter5582
in
MPN Voice
9 days ago
second generation anti-androgens associated with cognitive and functional toxic effects
This study of 12 randomized clinical trials comprising 13 524 participants observed an increased risk of cognitive toxic effects, fatigue, and falls among individuals treated with second-generation AAs (abiraterone, apalutamide, darolutamide, or enzalutamide). A Systematic Review and Meta-analysis
This study of 12 randomized clinical trials comprising 13 524 participants observed an increased risk of cognitive toxic effects, fatigue, and falls among individuals treated with second-generation AAs (abiraterone, apalutamide, darolutamide, or enzalutamide). A Systematic Review and Meta-analysis
Graham49
in
Advanced Prostate Cancer
10 days ago
Measurable residual disease (MRD) status predicts Progression Free Survival (PFS) for patients with Chronic Lymphocytic Leukemia (CLL)
[i]Measurable residual disease (MRD) refers to the presence of disease at low levels not detected by conventional pathologic analysis. The association of MRD status as a surrogate end point of clinical outcome in chronic lymphocytic leukemia (CLL) has not been established in the era of targeted agents
[i]Measurable residual disease (MRD) refers to the presence of disease at low levels not detected by conventional pathologic analysis. The association of MRD status as a surrogate end point of clinical outcome in chronic lymphocytic leukemia (CLL) has not been established in the era of targeted agents
AussieNeil
Partner
in
CLL Support
11 days ago
PMRGCAuk Annual Meeting....I wasn't alone today~!!
After my dress rehearsal last week, I got up at 4:30 AM, Central Time in the States, and was the only person at the Zoom link. I'm thrilled to report that I remembered today, and there were quite a few people. It was wonderful to put faces to the names of HU staff, Trustees, and some 'soul sisters' from
After my dress rehearsal last week, I got up at 4:30 AM, Central Time in the States, and was the only person at the Zoom link. I'm thrilled to report that I remembered today, and there were quite a few people. It was wonderful to put faces to the names of HU staff, Trustees, and some 'soul sisters' from
Grammy80
in
PMRGCAuk
12 days ago
Abbott starts TRANSCEND study to evaluate the use of its DBS system to manage severe depression
Abbott announced it has initiated a pivotal clinical trial, called the TRANSCEND study, to evaluate the use of the company's deep brain stimulation (DBS) system to manage treatment-resistant depression (TRD), a form of major depressive disorder. The US Food and Drug Administration (FDA) granted Abbott
Abbott announced it has initiated a pivotal clinical trial, called the TRANSCEND study, to evaluate the use of the company's deep brain stimulation (DBS) system to manage treatment-resistant depression (TRD), a form of major depressive disorder. The US Food and Drug Administration (FDA) granted Abbott
Farooqji
in
Cure Parkinson's
13 days ago
chemotherapy or something better?
hello. so I just had one week of radiation on my pelvic bone. And one day on my shoulder. From the MRI it shows the prostate cancer in the prostate isn’t spreading and actually getting smaller while the prostate cancer in my bones is actively spreading. On the CT scan it showed a new tumor unsure if
hello. so I just had one week of radiation on my pelvic bone. And one day on my shoulder. From the MRI it shows the prostate cancer in the prostate isn’t spreading and actually getting smaller while the prostate cancer in my bones is actively spreading. On the CT scan it showed a new tumor unsure if
BonnieKlyde
in
Advanced Prostate Cancer
13 days ago
Dose reductions
I just saw my oncologist today and she agreed to lower my Ibrance from 100 to 75! Oncologists are finally getting it. Hoping to have more energy in the future. I also asked her about the studies that say every other day for AI is also sufficient. She seem a little hesitant to endorse that (not surprised
I just saw my oncologist today and she agreed to lower my Ibrance from 100 to 75! Oncologists are finally getting it. Hoping to have more energy in the future. I also asked her about the studies that say every other day for AI is also sufficient. She seem a little hesitant to endorse that (not surprised
Suite1000
in
SHARE Metastatic Breast Cancer
14 days ago
Mindblowing (and hopefully actionable soon): Innovative In-Vivo Reprogramming to Transform Cancer Therapy
it could work also in the context of cold tumors like prostate cancer! The bad part, they think they will be ready for clinical trials in 2 years. A new immuno-oncology approach is being developed to reprogram tumor cells into dendritic cells directly within the patient, bypassing traditional cell therapy
it could work also in the context of cold tumors like prostate cancer! The bad part, they think they will be ready for clinical trials in 2 years. A new immuno-oncology approach is being developed to reprogram tumor cells into dendritic cells directly within the patient, bypassing traditional cell therapy
Maxone73
in
Advanced Prostate Cancer
17 days ago
ACTOv clinical trial
Hello All We've been asked to share the following information regarding a clinical trial: ACTOv is a clinical trial investigating a new personalised treatment approach to treat ovarian cancer that has relapsed (returned after previously receiving platinum chemotherapy treatment). The new treatment
Hello All We've been asked to share the following information regarding a clinical trial: ACTOv is a clinical trial investigating a new personalised treatment approach to treat ovarian cancer that has relapsed (returned after previously receiving platinum chemotherapy treatment). The new treatment
OvacomeSupport
My Ovacome Team
in
My Ovacome
17 days ago
Aussies will save us all: from Oz, a molecule that can (could) treat resistant prostate cancer
They will need some time still...but... "CDKI-73 is currently being investigated in Phase 2 clinical trials in patients with relapsed and therapy-resistant acute myeloid leukaemia, an aggressive blood cancer." Which means that at least we would not have to wait for a phase 1 to tell us the therapeutic
They will need some time still...but... "CDKI-73 is currently being investigated in Phase 2 clinical trials in patients with relapsed and therapy-resistant acute myeloid leukaemia, an aggressive blood cancer." Which means that at least we would not have to wait for a phase 1 to tell us the therapeutic
Maxone73
in
Advanced Prostate Cancer
17 days ago
Starting Mavenclad Today
Edit: I have gone back and added in some details that I've remembered that might be helpful, so if you've read this in the past few days you may notice some changes. You are not crazy. A quick disclaimer: I'm sure everyone realizes that I may have made mistakes, and that recommendations for taking
Edit: I have gone back and added in some details that I've remembered that might be helpful, so if you've read this in the past few days you may notice some changes. You are not crazy. A quick disclaimer: I'm sure everyone realizes that I may have made mistakes, and that recommendations for taking
CatsandCars
in
My MSAA Community
17 days ago
Maybe This Is What We Need For Thyroid Sufferers
Following on from Rapunzel's post about TUK mission statement and how we could do with a campaign or high profile celebrity to raise awareness, I just spotted this article in the Guardian today. I wish them every success in trying to find better treatments and diagnosis for a truly awful disease. I
Following on from Rapunzel's post about TUK mission statement and how we could do with a campaign or high profile celebrity to raise awareness, I just spotted this article in the Guardian today. I wish them every success in trying to find better treatments and diagnosis for a truly awful disease. I
Sparklingsunshine
in
Thyroid UK
19 days ago
Clinical trial using dandelion root for leukemia in Canada.
H.”ere is an article that some might be interested in: There are many more news articles about this. The research was done at University of Windsor in Canada and the clinical trial is at the Windsor Cancer Center. There is also some ongoing research of cancer cells and various types of mushroom
H.”ere is an article that some might be interested in: There are many more news articles about this. The research was done at University of Windsor in Canada and the clinical trial is at the Windsor Cancer Center. There is also some ongoing research of cancer cells and various types of mushroom
montieth
in
CLL Support
20 days ago
Have you or a loved one been diagnosed with a Glioblastoma?
Researchers in Oxford are in the early stages of a planning a new clinical trial called Recurrent-GB for patients diagnosed with a Glioblastoma and would greatly appreciate any feedback on the trial design. This survey will take approximately 5 minutes to complete and can be completed by a patient
Researchers in Oxford are in the early stages of a planning a new clinical trial called Recurrent-GB for patients diagnosed with a Glioblastoma and would greatly appreciate any feedback on the trial design. This survey will take approximately 5 minutes to complete and can be completed by a patient
Maddie_TBTC
Administrator
in
Glioblastoma Support
20 days ago
1
2
...
100
Next page
10
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
1323 results
Cure Parkinson's
663 results
CLL Support
631 results
View top 10 communities
Sort by
Most Relevant
Newest